← FDA Drug Approvals (Drugs@FDA)
GLYCOPYRROLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: OMNIVIUM PHARMS · Approved 2022-11-28
Drug application
- FDA Application #
ANDA212871- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GLYCOPYRROLATE
- Generic name
- Glycopyrrolate
- Active ingredients
- GLYCOPYRROLATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- OMNIVIUM PHARMS
- First approval
- 2022-11-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown